Zevra Therapeutics Appoints Justin Renz as Chief Financial Officer

PUBLISHED Thursday, March 5, 2026 · globe newswire

AI BRIEFING

⬤ Justin Renz appointed as CFO of Zevra Therapeutics, bringing over 25 years of financial leadership experience in biopharmaceutical industry.
⬤ Renz to take over as CFO on March 9, 2026, with a strong track record of driving growth and creating shareholder value.
⬤ Previous experience includes roles at Ardelyx and Correvio Pharma, with expertise in capital markets, strategic transactions and commercial-stage operations.